Plasma cefazolin levels during cardiovascular surgery: Effects of cardiopulmonary bypass and profound hypothermic circulatory arrest

Journal of Thoracic and Cardiovascular Surgery

Volumn 131, Issue 6, 2006, Pages 1338-1343

  Caffarelli, Anthony D ^a   Holden, Jeff P ^a   Baron, Ellen Jo ^b   Lemmens, Harry J M ^a   D'Souza, Holly ^b   Yau, Vincent ^b   Olcott IV, Cornelius ^a   Reitz, Bruce A ^a   Miller, D Craig ^a   van der Starre, Pieter J A ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HEART ARREST; HEART SURGERY; HUMAN; MALE; PRIORITY JOURNAL; SKIN INCISION; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND; WOUND CLOSURE;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARDIOPULMONARY BYPASS; CEFAZOLIN; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 33646853335     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.11.047     Document Type: Article

References (20)

1. L'Ecuyer P.B., Murphy D., Little J.R., and Fraser V.J. The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis. 22 (1996) 424-429
2. Lowy F.D., Waldhausen J.A., Miller M., Sopko G., Rosenberg Y., and Skarlatos S.I. Report of the National Heart, Lung and Blood Institute-National Institute of Allergy and Infectious Diseases working group on antimicrobial strategies and cardiothoracic surgery. Am Heart J. 147 (2004) 575-581
3. Klassen M., and Edberg S.C. Measurements of antibiotics in human body fluidstechniques and significance. In: Lorian V. (Ed). antibiotics in laboratory medicine. 4th ed. (1996), Williams & Wilkins, Baltimore 230-239
4. Fellinger E.K., Leavitt B.J., and Hebert J.C. Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery. Ann Thorac Surg. 74 (2002) 1187-1190
5. Milano C.A., Kesler K., Archibald N., Sexton D.J., and Jones R.H. Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation. 92 (1995) 2245-2251
6. Kappstein I., Schulgen G., Fraedrich G., Schlosser V., Schumacher M., and Daschner F.D. Added hospital stay due to wound infections following cardiac surgery. Thorac Cardiovasc Surg. 40 (1992) 148-151
7. Asensio A., and Torres J. Quantifying excess length of postoperative stay attributable to infections. a comparison of methods. J Clin Epidemiol. 52 (1999) 1249-1256
8. Toumpoulis I.K., Anagnostopoulos C.E., DeRose Jr. J.J., and Swistel D.G. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest. 127 (2005) 464-471
9. Kreter B., and Woods M. Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg. 104 (1992) 590-599
10. Kalman D., and Barriere S.L. Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins. Tex Heart Inst J. 17 (1990) 203-215
11. Lehot J.J., Reverdy M.E., Etienne J., et al. Cefazolin and netilmicin serum levels during and after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Anesth. 4 (1990) 204-209
12. Osmon D.R. Antimicrobial prophylaxis in adults. Mayo Clin Proc. 75 (2000) 98-109
13. Bucknell S.J., Mohajeri M., Low J., McDonald M., and Hill D.G. Single-versus multiple-dose antibiotics prophylaxis for cardiac surgery. Aust N Z J Surg. 70 (2000) 409-411
14. Zanetti G., Giardina R., and Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis. 7 (2001) 828-831
15. Naziri W., Cheadle W.G., Trachtenberg L.S., Montgomery W.D., and Polk Jr. H.C. Second place winner of the Conrad Jobst Award in the gold medal paper competition. Increased antibiotic effectiveness in a model of surgical infection through continuous infusion. Am Surg. 61 (1995) 11-15
16. Classen D.C., Evans R.S., Pestotnik S.L., Horn S.D., Menlove R.L., and Burke J.P. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 326 (1992) 281-286
17. Edwards Jr. W.H., Kaiser A.B., Kernodle D.S., et al. Cefuroxime versus cefazolin as prophylaxis in vascular surgery. J Vasc Surg. 15 (1992) 35-41
18. Barza M. Pharmacokinetics of antibiotics in shallow and deep compartments. J Antimicrob Chemother. 31 suppl D (1993) 17-27
19. Bergamini T.M., and Polk Jr. H.C. Pharmacodynamics of antibiotic penetration of tissue and surgical prophylaxis. Surg Gynecol Obstet. 168 (1989) 283-289
20. Maki D.G., Bohn M.J., Stolz S.M., Kroncke G.M., Acher C.W., and Myerowitz P.D. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. J Thorac Cardiovasc Surg. 104 (1992) 1423-1434